The management of infectious diseases is a major global health issue. The Nanōmix system can be used to save lives in developing countries by enabling local communities to better diagnose and manage infectious diseases at the point of care. Without access to healthcare infrastructure that is present in the Developed World, a test system that does not require a centralized lab, hospital or even a doctor can mean the difference in survival of millions of people.
The Nanōmix system can be adapted into a low cost consumable version to meet the significant demand for decentralized laboratory testing in lower resource settings such as developing countries and remote settings.
Nanōmix, along with its collaborators, field tested a multiplexed diagnostic for Ebola, Lassa and Dengue in Sierra Leone. This work was presented at the American Association for Clinical Chemistry (AACC).
Please visit our Ebola page for more information.
Integrating carbon nanostructure detection elements with proprietary chemistries, Nanōmix is developing high-value detection devices capable of ultrasensitive, specific and multiplexed detection of proteins, nucleic acids and metabolite chemistries within a single test reaction.
Nanōmix licenses its technology and provides development and manufacturing services for companies that wish to use our technology platform to deliver diagnostic products. Services include engineering, chemistry and assay development as well as performance testing.
If you would like to collaborate with us this area please Contact Us.